IB

International BM Biomedicine Holdings AG

Europe, Basel-Stadt, Switzerland, Basel

Description

International BM Biomedicine Holdings AG invests in biopharmaceutical companies located in the United States.

Investor Profile

International BM Biomedicine Holdings AG has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 50% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biopharma, Biotechnology, Health Care.

Stage Focus

  • Series B (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Health Care
  • Innovation Management
  • Medical
  • Professional Services
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does International BM Biomedicine Holdings AG frequently co-invest with?

DeNovo Ventures
North America, California, United States, Saratoga
Co-Investments: 1
Duke University
North America, North Carolina, United States, Durham
Co-Investments: 1
Sevin Rosen Funds
North America, Texas, United States, Dallas
Co-Investments: 1
Mayfield Fund
North America, California, United States, Menlo Park
Co-Investments: 1
Bosch Capital
Europe, Moscow City, Russian Federation, Moscow
Co-Investments: 1
NM
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
BioVeda Capital
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 1
Vulcan
North America, Washington, United States, Seattle
Co-Investments: 1
Flagship Pioneering
North America, Massachusetts, United States, Cambridge
Co-Investments: 1

What are some of recent deals done by International BM Biomedicine Holdings AG?

Renovis

South San Francisco, California, United States

Renovis,is a biopharmaceutical company developing drugs to treat neurological diseases and disorders.

Innovation ManagementMedicalProfessional Services
Series BJan 10, 2002
Amount Raised: $34,300,000
Cytokinetics

South San Francisco, California, United States

Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.

BiopharmaBiotechnologyHealth Care
Series BOct 12, 1999
Amount Raised: $20,000,000